RAFAEL HOLDINGS, INC. Accounts Receivable, Related Parties, Current
RAFAEL HOLDINGS, INC. (RFL) had Accounts Receivable, Related Parties, Current of $720.00 thousand as of 2022-07-31, per its 10-K filed 2022-10-31.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2022-10-31
- 2022-07-31: Accounts Receivable, Related Parties, Current $720.00K.
- 2022-04-30: Accounts Receivable, Related Parties, Current $720.00K.
- 2022-01-31: Accounts Receivable, Related Parties, Current $720.00K.
- 2021-10-31: Accounts Receivable, Related Parties, Current $720.00K.
| Period end | Accounts Receivable, Related Parties, Current | Accounts Receivable, Related Parties, Current as first filed |
|---|---|---|
| 2022-07-31 | $720.00K 10-K · filed 2022-10-31 | |
| 2022-04-30 | $720.00K 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $720.00K 10-Q · filed 2022-03-17 | |
| 2021-10-31 | $720.00K 10-Q/A · filed 2022-02-28 | |
| 2021-07-31 | $0.00 10-K · filed 2022-10-31 | $113.00K 10-K · filed 2021-10-18 |
| 2021-04-30 | $144.00K 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $111.00K 10-Q · filed 2021-03-17 | |
| 2020-10-31 | $150.00K 10-Q · filed 2020-12-15 | |
| 2020-07-31 | $121.00K 10-K · filed 2021-10-18 | |
| 2020-04-30 | $137.00K 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $46.00K 10-Q · filed 2020-03-05 | |
| 2019-10-31 | $20.00K 10-Q · filed 2019-12-09 | |
| 2019-07-31 | $11.00K 10-K · filed 2020-10-29 | |
| 2019-04-30 | $11.00K 10-Q · filed 2019-06-05 | |
| 2019-01-31 | $12.00K 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $10.00K 10-Q · filed 2018-12-10 | |
| 2018-07-31 | $11.00K 10-K · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |